4-{4-[5-(2-Methoxy-phenyl)-[1,3,4]oxadiazol-2-yl]-phenyl}-morpholine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 4-{4-[5-(2-Methoxy-phenyl)-[1,3,4]oxadiazol-2-yl]-phenyl}-morpholine
• 英文别名: 4-[4-[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]phenyl]morpholine
• 化学式: C₁₉H₁₉N₃O₃
• 分子量: 337.4
• InChiKey: GMWPCVYUMMCNBX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  60.6
• 氢给体数：
  0
• 氢受体数：
  6

文献信息

• DIAGNOSTIC PROBE FOR CONFORMATION DISEASE
  申请人：Kudo Yukitsuka

  公开号：US20090185975A1

  公开（公告）日：2009-07-23

  The invention provides a probe compound useful for early diagnosis of conformation disease, a composition and a kit comprising it for diagnosis for conformation disease, and a medical composition for treatment and/or prevention of conformation disease.
• BENZOXAZOLE DERIVATIVES
  申请人：Kudo Yukitsuka

  公开号：US20100021385A1

  公开（公告）日：2010-01-28

  It is intended to provide a benzoxazole derivative or a pharmaceutically acceptable salt or solvate thereof which is useful in the early diagnosis of a conformation disease; a composition or a kit containing the same for diagnosing a conformation disease; a medical composition for treating and/or preventing a conformation disease; and so on.
• US7910579B2
  申请人：——

  公开号：US7910579B2

  公开（公告）日：2011-03-22